NEW YORK, Aug. 08, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) between April 30, 2013 and May 16, 2017. You are hereby notified that a securities class action lawsuit has been commenced in District of New Jersey. To get more information go to:
http://www.zlk.com/pslra-sba/sinovac-biotech-ltd?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Defendant Weidong Yin, Sinovac’s Chairman and CEO, bribed a member of the Chinese Food and Drug Administration to assist Sinovac’s vaccine clinical trial and approval; (2) Yin's conduct would subject Sinovac to heightened regulatory scrutiny; and (3) subsequently, Sinovac’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Sinovac Biotech Ltd. you have until September 1, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Bill Ackman Eyes New Fund to Bet Against Market Complacency
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 



